搜尋





搜尋





市場行情
/
股票
/
xers
/

Xeris Biopharma Holdings Inc

XERS

添加自選

8.080USD

-0.340-4.04%

收盤 07-31 16:00（美東）報價延遲15分鐘

1.39B總市值

104.89本益比TTM

Xeris Biopharma Holdings Inc

8.080

-0.340-4.04%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

XERS 利潤表

您可以在這裡找到Xeris Biopharma Holdings Inc的年度或季度收入報告，以深入了解Xeris Biopharma Holdings Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

營業總收入

38.27%83.13M

42.78%85.81M

37.06%74.38M

48.84%71.54M

47.94%60.12M

35.39%60.10M

12.31%54.27M

26.46%48.06M

22.42%40.64M

33.93%44.39M

62.56%48.32M

50.19%38.01M

50.39%33.20M

54.67%33.14M

168.76%29.73M

184.15%25.31M

169.35%22.07M

198.79%21.43M

17.06%11.06M

339.37%8.91M

358.33%8.20M

291.70%7.17M

2918.53%9.45M

582.49%2.03M

620.97%1.79M

128.59%1.83M

-46.22%313.00K

-63.74%297.00K

-5.70%248.00K

71.52%801.00K

242.35%582.00K

44.96%819.00K

-25.71%263.00K

--467.00K

--170.00K

--565.00K

--354.00K

營業收入

38.27%83.13M

42.78%85.81M

37.06%74.38M

48.84%71.54M

47.94%60.12M

35.39%60.10M

12.31%54.27M

26.46%48.06M

22.42%40.64M

33.93%44.39M

62.56%48.32M

50.19%38.01M

50.39%33.20M

54.67%33.14M

168.76%29.73M

184.15%25.31M

169.35%22.07M

198.79%21.43M

17.06%11.06M

339.37%8.91M

358.33%8.20M

291.70%7.17M

2918.53%9.45M

582.49%2.03M

620.97%1.79M

128.59%1.83M

-46.22%313.00K

-63.74%297.00K

-5.70%248.00K

71.52%801.00K

242.35%582.00K

44.96%819.00K

-25.71%263.00K

--467.00K

--170.00K

--565.00K

--354.00K

主營業務成本

16.14%13.28M

12.05%13.66M

-15.93%13.71M

39.13%14.61M

31.74%11.44M

18.56%12.19M

49.41%16.30M

2.29%10.50M

8.12%8.68M

14.21%10.28M

36.90%10.91M

36.50%10.27M

-10.62%8.03M

65.51%9.00M

147.55%7.97M

122.29%7.52M

392.00%8.98M

59.64%5.44M

13.70%3.22M

160.43%3.38M

2.01%1.83M

117.01%3.41M

--2.83M

--1.30M

--1.79M

--1.57M

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--42.00K

--0.00

--4.00K

--0.00

營業費用

18.99%75.21M

18.17%69.03M

0.73%67.65M

19.21%67.06M

15.17%63.21M

7.72%58.42M

26.16%67.16M

4.20%56.25M

18.10%54.88M

12.25%54.23M

9.97%53.23M

22.08%53.99M

12.94%46.47M

-28.42%48.31M

46.16%48.41M

43.61%44.22M

67.03%41.15M

154.57%67.50M

42.80%33.12M

27.08%30.79M

-18.00%24.64M

-23.44%26.52M

-23.70%23.19M

-29.47%24.23M

16.96%30.04M

64.02%34.63M

95.78%30.39M

160.75%34.36M

114.17%25.68M

118.22%21.11M

100.53%15.53M

128.59%13.18M

139.72%11.99M

--9.68M

--7.74M

--5.76M

--5.00M

研發費用

13.29%8.78M

29.25%7.87M

27.09%7.48M

39.87%8.05M

-0.87%7.75M

-4.54%6.09M

16.96%5.89M

-5.39%5.76M

61.66%7.82M

28.80%6.38M

-16.70%5.03M

63.72%6.09M

-22.59%4.84M

-50.85%4.96M

6.71%6.04M

-30.93%3.72M

67.47%6.25M

97.30%10.08M

46.10%5.66M

1.78%5.38M

-43.85%3.73M

-58.86%5.11M

-75.02%3.88M

-72.64%5.29M

-49.53%6.65M

0.24%12.42M

42.69%15.52M

122.81%19.33M

51.14%13.17M

88.36%12.39M

89.96%10.88M

106.55%8.68M

137.90%8.71M

--6.58M

--5.72M

--4.20M

--3.66M

折舊攤銷及損耗

-3.05%3.05M

-2.78%3.05M

-2.40%3.05M

-3.74%3.04M

-2.21%3.14M

-3.87%3.13M

-6.94%3.12M

-6.21%3.15M

1.04%3.21M

-6.97%3.26M

9.31%3.36M

9.83%3.36M

4.91%3.18M

289.66%3.50M

850.77%3.07M

856.88%3.06M

799.70%3.03M

101.57%899.00K

-15.67%323.00K

0.63%320.00K

5.31%337.00K

17.37%446.00K

12.98%383.00K

41.33%318.00K

138.81%320.00K

118.39%380.00K

6680.00%339.00K

188.46%225.00K

112.70%134.00K

222.22%174.00K

-90.38%5.00K

136.36%78.00K

65.79%63.00K

--54.00K

--52.00K

--33.00K

--38.00K

營業利潤

356.18%7.92M

898.99%16.77M

152.21%6.73M

154.75%4.48M

78.31%-3.09M

117.06%1.68M

-162.43%-12.89M

48.76%-8.19M

-7.29%-14.24M

35.13%-9.84M

73.70%-4.91M

15.53%-15.98M

30.39%-13.28M

67.07%-15.17M

15.31%-18.68M

13.57%-18.92M

-16.02%-19.07M

-138.18%-46.07M

-60.49%-22.06M

1.43%-21.89M

41.81%-16.44M

41.03%-19.34M

54.31%-13.74M

34.81%-22.20M

-11.07%-28.25M

-61.47%-32.80M

-101.31%-30.08M

-175.63%-34.06M

-116.85%-25.44M

-120.59%-20.31M

-97.35%-14.94M

-137.68%-12.36M

-152.31%-11.73M

---9.21M

---7.57M

---5.20M

---4.65M

淨非營業利息收入（費用）

利息收入

2.30%1.20M

60.55%1.46M

-3.26%1.16M

-26.57%948.00K

-38.90%1.18M

-17.80%910.00K

6.78%1.20M

5.56%1.29M

47.92%1.92M

-39.93%1.11M

137.50%1.12M

527.18%1.22M

1811.76%1.30M

2532.86%1.84M

615.15%472.00K

153.25%195.00K

-32.00%68.00K

-96.54%70.00K

-71.55%66.00K

-72.20%77.00K

-76.96%100.00K

215.94%2.02M

-64.69%232.00K

-67.22%277.00K

-35.32%434.00K

-21.66%640.00K

42.21%657.00K

255.04%845.00K

598.96%671.00K

934.18%817.00K

926.67%462.00K

--238.00K

--96.00K

--79.00K

--45.00K

--0.00

利息費用

-5.76%6.88M

-7.14%7.15M

-6.65%7.27M

-7.61%7.36M

3.88%7.30M

9.76%7.70M

13.71%7.79M

22.00%7.96M

13.13%7.03M

60.71%7.02M

71.65%6.85M

83.99%6.53M

179.87%6.22M

143.15%4.37M

121.86%3.99M

97.66%3.55M

24.01%2.22M

-60.88%1.80M

-22.77%1.80M

19.75%1.79M

19.48%1.79M

199.87%4.59M

-33.62%2.33M

41.15%1.50M

41.02%1.50M

45.12%1.53M

375.85%3.51M

88.97%1.06M

456.54%1.06M

105400.00%1.05M

--737.00K

56100.00%562.00K

--191.00K

--1.00K

--0.00

--1.00K

--0.00

特殊收入（費用）

----

-100.00%0.00

-99.95%1.00K

122.25%420.00K

-21.25%604.00K

-49.89%681.00K

-51.97%2.13M

-7092.59%-1.89M

118.03%767.00K

110.54%1.36M

247.88%4.43M

101.22%27.00K

-8.82%-4.25M

-4505.36%-12.89M

-5541.82%-2.99M

-1286.88%-2.22M

-400.00%-3.91M

-307.41%-280.00K

-63.82%55.00K

-266.67%-160.00K

-624.07%-782.00K

-75.54%135.00K

14.29%152.00K

-78.71%96.00K

64.71%-108.00K

773.17%552.00K

1050.00%133.00K

--451.00K

-856.25%-306.00K

---82.00K

---14.00K

--0.00

---32.00K

--0.00

其他非經營性收入（費用）

---5.68M

----

100.00%0.00

----

---1.00K

----

稅前利潤

124.23%2.23M

316.72%11.08M

103.26%621.00K

86.48%-1.93M

50.62%-9.22M

62.48%-5.11M

-52.17%-19.06M

30.52%-14.26M

-10.92%-18.67M

-2.70%-13.63M

43.50%-12.53M

22.65%-20.52M

50.67%-16.83M

73.88%-13.27M

14.76%-22.17M

3.60%-26.52M

-85.33%-34.12M

-132.37%-50.79M

-62.56%-26.01M

-13.66%-27.52M

36.91%-18.41M

34.83%-21.86M

51.27%-16.00M

29.59%-24.21M

-15.46%-29.18M

-64.26%-33.54M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

所得稅

--0.00

100.00%0.00

-100.00%0.00

100.00%0.00

-883.43%-3.32M

210.96%749.00K

--307.00K

30.18%-236.00K

0.29%-338.00K

-99.12%-675.00K

100.00%0.00

---338.00K

---339.00K

---408.00K

--0.00

100.00%0.00

--0.00

100.00%0.00

--0.00

---110.00K

----

---458.00K

--0.00

----

除稅後利潤

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

持續經營利潤

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

歸属于母公司的淨利潤

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

歸屬普通股東的淨利潤

124.23%2.23M

316.72%11.08M

103.95%621.00K

87.15%-1.93M

51.42%-9.22M

61.81%-5.11M

-29.12%-15.74M

24.38%-15.01M

-12.75%-18.98M

-3.56%-13.39M

44.17%-12.19M

24.22%-19.84M

50.07%-16.83M

74.54%-12.93M

16.06%-21.83M

4.83%-26.18M

-83.12%-33.71M

-132.37%-50.79M

-62.56%-26.01M

-14.17%-27.52M

36.91%-18.41M

33.93%-21.86M

51.27%-16.00M

29.91%-24.10M

-15.46%-29.18M

-62.02%-33.08M

-122.36%-32.84M

-164.76%-34.38M

-112.29%-25.28M

-123.26%-20.42M

-96.19%-14.77M

-148.22%-12.99M

-156.12%-11.91M

---9.15M

---7.53M

---5.23M

---4.65M

基本每股收益

121.66%0.01

294.75%0.07

103.59%0.00

88.05%-0.01

55.23%-0.06

64.65%-0.03

-19.64%-0.11

29.99%-0.10

-10.04%-0.14

-1.96%-0.10

45.02%-0.09

25.22%-0.14

50.84%-0.12

77.17%-0.10

58.94%-0.16

53.40%-0.19

16.95%-0.25

-2.11%-0.42

-12.81%-0.39

34.67%-0.41

66.22%-0.30

66.70%-0.41

71.55%-0.35

50.37%-0.63

17.04%-0.89

-25.76%-1.22

-71.30%-1.22

-103.71%-1.28

-77.82%-1.07

-110.15%-0.97

-86.55%-0.71

-136.79%-0.63

-156.12%-0.60

---0.46

---0.38

---0.27

---0.24

稀釋每股收益

120.80%0.01

250.19%0.05

103.31%0.00

88.05%-0.01

55.23%-0.06

64.65%-0.03

-19.64%-0.11

29.99%-0.10

-10.04%-0.14

-1.96%-0.10

45.02%-0.09

25.22%-0.14

50.84%-0.12

77.17%-0.10

58.94%-0.16

53.40%-0.19

16.95%-0.25

-2.11%-0.42

-12.81%-0.39

34.67%-0.41

66.22%-0.30

66.70%-0.41

71.55%-0.35

50.37%-0.63

17.04%-0.89

-25.76%-1.22

-71.30%-1.22

-103.71%-1.28

-77.82%-1.07

-110.15%-0.97

-86.55%-0.71

-136.79%-0.63

-156.12%-0.60

---0.46

---0.38

---0.27

---0.24

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Xeris Biopharma Holdings Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 XERS 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Xeris Biopharma Holdings Inc 財年末的營收是多少？



Xeris Biopharma Holdings Inc 2025 財年營收為 291.85M，高於上一財年的 203.07M。

Xeris Biopharma Holdings Inc 最近一個季度的營收是多少？



Xeris Biopharma Holdings Inc 最近一個季度的營收為 83.13M，同比增長 38.27%。

Xeris Biopharma Holdings Inc 全年的淨利潤是多少？



Xeris Biopharma Holdings Inc 2025 財年淨利潤為 554.00K。

Xeris Biopharma Holdings Inc 上一季度的淨利潤是多少？



Xeris Biopharma Holdings Inc 最近一個季度的淨利潤為 2.23M。

Xeris Biopharma Holdings Inc 年度營業利潤是多少？



Xeris Biopharma Holdings Inc 2025 財年的營業利潤為 24.90M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。